Athira Pharma, Inc.

Athira Pharma, Inc.verified

ATHA

Price:

$0.642

Market Cap:

$24.83M

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkinson's disease. It also develops product candidates, which are in preclinical stage, including ATH-1019 for peripheral nervous system indications; and ATH-1020 for neuropsychiatric conditions. Athira Pharma, Inc. was formerly known as M3 Biotechnology,...[Read more]

Industry

Biotechnology

IPO Date

2020-09-18

Stock Exchange

NASDAQ

Ticker

ATHA

The Enterprise Value as of November 2024 (TTM) for Athira Pharma, Inc. (ATHA) is -42716438.00

According to Athira Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -42716438.00. This represents a change of 1.41% compared to the average of -2837589.72 of the last 4 quarters.

Athira Pharma, Inc. (ATHA) Historical Enterprise Value (quarterly & annually)

How has ATHA Enterprise Value performed in the past?

The mean historical Enterprise Value of Athira Pharma, Inc. over the last ten years is 352.55M. The current -42716438.00 Enterprise Value has changed -1311.64% with respect to the historical average. Over the past ten years (40 quarters), ATHA's Enterprise Value was at its highest in in the December 2020 quarter at 1.17B. The Enterprise Value was at its lowest in in the September 2024 quarter at -50363149.51.

Quarterly (TTM)
Annual

Average

352.55M

Median

237.86M

Minimum

3.39M

Maximum

1.05B

Athira Pharma, Inc. (ATHA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Athira Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 440.02%

Maximum Annual Enterprise Value = 1.05B

Minimum Annual Increase = -93.14%

Minimum Annual Enterprise Value = 3.39M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20233.39M-86.74%
202225.56M-93.14%
2021372.47M-64.63%
20201.05B88.84%
2019557.61M440.02%

Athira Pharma, Inc. (ATHA) Average Enterprise Value

How has ATHA Enterprise Value performed in the past?

The current Enterprise Value of Athira Pharma, Inc. (ATHA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

133.80M

5-year avg

402.41M

10-year avg

352.55M

Athira Pharma, Inc. (ATHA) Enterprise Value vs. Peers

How is ATHA’s Enterprise Value compared to its peers?

Athira Pharma, Inc.’s Enterprise Value is less than CytomX Therapeutics, Inc. (39.67M), less than Spero Therapeutics, Inc. (-8426888.00), less than Neoleukin Therapeutics, Inc. (-6333315.00), less than Instil Bio, Inc. (165.40M), less than NextCure, Inc. (11.01M), less than Assembly Biosciences, Inc. (68.59M), less than Achilles Therapeutics plc (-38865958.00), less than Nuvation Bio Inc. (923.54M),

CompanyEnterprise ValueMarket cap
39.67M$69.65M
-8426888.00$63.24M
-6333315.00$8.20M
165.40M$170.65M
11.01M$33.33M
68.59M$95.60M
-38865958.00$43.57M
923.54M$942.39M

Build a custom stock screener for Athira Pharma, Inc. (ATHA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Athira Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Athira Pharma, Inc. (ATHA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Athira Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Athira Pharma, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Athira Pharma, Inc. (ATHA)?

What is the 3-year average Enterprise Value for Athira Pharma, Inc. (ATHA)?

What is the 5-year average Enterprise Value for Athira Pharma, Inc. (ATHA)?

How does the current Enterprise Value for Athira Pharma, Inc. (ATHA) compare to its historical average?